As far as Joe, I've had good conversations with him him in the past and he seems like a nice guy. I like the fact he would never reveal or talk about non-public information. Early 2021 things appeared to be heading in a positive direction & Joe appeared to have a good understanding of where we were heading. If folks remember, even with positive things going on, our share price still wasn't that good. Since that early CC, there has not been much to hang our hats on. I know there's a few that don't like negative post but it's better to be honest with where things are at so folks are not misguided and can make a better evaluation of our stock. Back to Joe, in my more recent conversations with Joe, he spent most of his time displaying his discourse with how the investigation was going. There is no official accounting of what's going on with the investigation and where things are at for all of us to see. But, make no mistake, if it's gone on for two years as Joe says, then it doesn't take a rocket scientist to figure out things have gotten pretty serious. I can tell you this, I'm not the only one who has spoken to Joe and/or company officials, so I encourage anyone who has any information to help folks evaluate GNBT/NGIO then let's bring it out. As far as our stock price, it's a reflection of what the market thinks. Hey, I hate it that my remaining shares are about as red as you could get. I also understand that there are many who have been here much longer when the share price was in the dollars. So, I hate it for them to see where things have gone. And once again, the market reflects it. GLTA!
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Nasdaq Drops 1% Amid Chip and Megacap Share Decline
Loss in chip and megacap stocks drove Tuesday's 1% drop in the Nasdaq. Before important results from big technology companies, investors were wary. With a 5% drop, Nvidia led the fall that profoundly affected the semiconductor industry. Other tech behemoths including Apple, Amazon, and Tesla likewise saw declining shares. This cautious attitude resulted from worries about the longevity of recent increases in several high-growth stocks. T... Continue Reading
June Sees Modest Drop in U.S. Job Openings
American job openings dropped 46,000 to 8.184 million in June. This meager drop points to a slow down of the labor market over time. This statistics came from the Job Openings and Labor Turnover Survey (JOLTS) published by the Bureau of Labor Statistics. Job openings remain rather high even with the decline. For June, economists had foresaw 8.0 million vacancies. The fall is a consistent one since March 2022. This moderation fits the interest rate in... Continue Reading
U.S. Single-Family Home Prices Remain Steady in May
Reflecting a stabilizing of the housing market, U.S. single-family home prices in May remained unchanged. Following a 0.3% rise in April, this flat performance showed a cooling trend. With this same reading, the Federal Housing Finance Agency (FHFA) indicated that the market is getting used to rising mortgage rates. Consistent home prices point to an equilibrium between supply and demand. Potential purchasers who have seen quick price increa... Continue Reading
Introduction to ADIA Nutrition and Cement Factory Nutrition Partnership
Strategic cooperation with health and wellness company Cement Factory Nutrition has been announced by ADIA Nutrition (OTC Pink: ADIA). This cooperation seeks to diversify and improve ADIA's range of products for the nutrition and supplement sectors. As ADIA Nutrition aims to increase its market presence, the cooperation represents a significant forward for the company. Former WWE wrestler Jeffrey Sciullo, sometimes kn... Continue Reading
Bank of Botetourt Reports Increased Q2 2024 Earnings
Declaring its Q2 2024 financial results, Bank of Botetourt revealed a net income of $2,193,000, or $1.06 per basic share. This is a rise from the $1,993,000 or $0.96 per share stated in the same period previous year. The bank ascribed this increase in growth on higher loan interest and fees, which climbed by $2,134,000. Also helping to produce the good outcomes was less provision for credit losses, down by $360,000. On loans and deposits, t... Continue Reading
Overview of Tilray Brands, Inc.
Tilray Brands, Inc. (NASDAQ: TLRY) is a pioneering company in the field of medical and recreational cannabis production and research. Headquartered in Canada, Tilray has positioned itself as a global leader with a commitment to providing safe, consistent, and reliable therapy to patients and consumers worldwide. The company operates in multiple regions, including Canada, the United States, Europe, Australia, and Latin America, serving a diverse clientele rangin... Continue Reading
Introduction to Demand Generation
In the fast-paced world of digital marketing and advertising, understanding the demand generation process is crucial for business growth. Demand generation is a comprehensive strategy aimed at creating awareness and interest in a company's products or services, ultimately driving customer engagement and revenue. For advertisers, especially in the realm of connected TV advertising, mastering demand generation can significantly enhance performance marketing... Continue Reading
Philips Reports Strong Order Intake Growth in Q2 2024
With a 9% rise over past periods, Philips's order intake in Q2 2024 rose significantly. Mostly, the North American market drove this expansion. With group sales of EUR 4.5 billion, the company said that comparable sales had risen by 2%. Operations brought in EUR 816 million, of which EUR 538 million came from insurance earnings. The changed EBITA margin climbed to 11.1% of sales. Apart from a free cash outflow of EUR 64 million, Philip... Continue Reading
Burcon NutraScience Achieves Milestone in Canola Protein Production
Leader in plant-based protein technologies, Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) has effectively finished its first end-to-end validation trial for manufacturing high-purity canola protein isolate. For Burcon's goal of releasing creative, plant-based protein solutions onto the market, this success represents a major forward step.
Commercialization of Canola Protein Technology
Burcon's commerc... Continue Reading
Category: StocksTotal Views: 301 By : Caleb PriceUpdated: 07-29-2024
Acquisition of Mineral Claims in Athabasca Basin
Skyharbour Resources LTD. has signed an asset purchase agreement with Cosa Resources Corp. Signed July 26, 2024, the agreement calls for acquiring two mineral claims in the Athabasca Basin, Saskatchewan. With 12,718 hectares, these claims will double the footprint of the Orbit uranium project. With this purchase, Cosa will be able to increase its eight kilometer control of untested strike length. The claims follow trend with uranium mineralizat... Continue Reading